Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Echistatin is a potent inhibitor of bone resorption in culture.

Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ.

J Cell Biol. 1990 Oct;111(4):1713-23.

2.
3.

Integrin function in osteoclasts.

Rodan SB, Rodan GA.

J Endocrinol. 1997 Sep;154 Suppl:S47-56. Review.

4.

Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.

Duong LT, Rodan GA.

Front Biosci. 1998 Aug 1;3:d757-68. Review.

PMID:
9682033
5.

Integrin-dependent mobilization of intracellular calcium ions in osteoclasts. A possible role in the regulation of the secretion of protons and lysosomal enzymes.

Davison I, Shankar G, Horton MA, Mason WT.

Ann N Y Acad Sci. 1994 Mar 9;710:287-300. Review. No abstract available.

PMID:
8154755
6.

Approach to discovering novel therapeutic agents for osteoporosis based on integrin receptor blockade.

Chorev M, Dresner-Pollak R, Eshel Y, Rosenblatt M.

Biopolymers. 1995;37(6):367-75. Review.

PMID:
8589242
7.

Echistatin, a potential new drug for osteoporosis.

Oursler MJ, Spelsberg TC.

Endocrinology. 1993 Mar;132(3):939-40. Review. No abstract available.

PMID:
8440196

Supplemental Content

Support Center